Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence - Wikidata - awgldk - TriplyDB

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

http://www.wikidata.org/entity/Q28482202

about

Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention.Cytoprotective effects of hydrogen sulfide in novel rat models of non-erosive esophagitis.Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism.The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis.Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.NSAID enteropathy and bacteria: a complicated relationship.Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.Hydrogen sulfide signaling in the gastrointestinal tract.Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges.Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Management of NSAID-associated peptic ulcer disease.Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration.Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury.Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci.Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.Endogenous prostaglandins and afferent sensory nerves in gastroprotective effect of hydrogen sulfide against stress-induced gastric lesions.Differential visceral pain sensitivity and colonic morphology in four common laboratory rat strains.International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.H2S confers colonoprotection against TNBS-induced colitis by HO-1 upregulation in rats.

P2860

Q28083755-0F67FACA-07E0-401B-839D-A43166FD54DB Q28387183-747A5F2A-14FF-4991-8A84-EA9D97EA09CB Q28550361-2399BB72-20FC-4605-B477-E0316B414297 Q34195623-1D87144C-4E3F-495D-8845-B737A6CC12F6 Q34380226-CBAA2E7E-D71D-43A7-9BEE-39652DCD5CF2 Q34938166-FAC5167D-B3B0-48BD-9673-26D068213A71 Q35158599-C766EE71-D07A-44C3-956E-CC19BB105B5B Q35314338-D8D7D0F4-190A-4D0A-93C0-0C6B4500E0D4 Q35540435-06A9D1D1-7464-48D0-ACA4-4C1AA9EF3A44 Q38097424-BCB0B2EB-FD76-48E3-939E-385B539CED31 Q38098623-E6B3DD6A-1F36-4F65-B483-B6D84F293B46 Q38155495-B235DC65-A87C-45D9-ADED-8059AAAA28BC Q38236845-5BA70D06-B681-41A8-8399-08FFC8AABC7B Q38260626-2720312A-2974-4C60-96EF-22DAB2D322E5 Q38558587-D7439257-92E4-4732-80D1-63BE948891F1 Q38699305-9B9CC116-67D6-496B-A60A-EDD0666A7AF8 Q38707937-4F7C8CAF-B758-456E-B1B5-6218E3A0CAA6 Q39007494-29F6E8EE-749C-46A6-B9E4-03EB590BEC7B Q39053014-3FCB131B-375F-4DEF-8D40-9FB78D4D0367 Q39451528-0F696933-5DC0-4972-8FD6-44532ABED8E0 Q39710654-5BFC9EFD-3F3F-45A9-8E91-5CC4B129DCC6 Q41729974-CC40BC24-20B3-4691-A420-C5163C6A3959 Q43188421-49060895-4496-400A-9C1D-87DF533BE543 Q46129725-CA78A97F-13CB-4D9B-A669-3B0F119331CA Q47914860-6F6C2347-44CE-4468-9580-AB4D5602DB32 Q53128579-EA6C222A-BAE3-4A81-BEB0-90096CF0F23F

P2860

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

http://www.wikidata.org/entity/Q28482202

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@ast

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@en

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@nl

type

label

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@ast

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@en

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@nl

prefLabel

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@ast

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@en

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@nl

P1433

Q28482202-1AC3711F-A611-4C37-97ED-5FB42114E387

P1476

Q28482202-5EE19A65-BB5C-442B-AF76-38FDBDB3C910

P2093

Q28482202-49584B02-FEB0-45D2-87BB-7AB5AE6009F9

Q28482202-62913C2C-F94D-4C4B-9ECC-18CA2E1487BB

Q28482202-6EE0A84C-9E24-49E8-B7A3-4532388E4ACA

Q28482202-C3C42D9E-4EC9-458B-AF8D-C7484EEE8F45

Q28482202-D3E118C6-B253-4E8F-8CF6-D2A51D5CAEF4

P2860

Q28482202-0178300F-4411-465F-9EB7-6D06AF70D565

Q28482202-0B8E4039-8692-4792-B843-4412777C7AD5

Q28482202-0BF36AC0-CD89-44AC-B071-76F5757104A6

Q28482202-2688C937-E5CB-4D7A-A2A5-71C8938DD0A3

Q28482202-269F0CAF-B2E8-457D-987E-1C126FAC2E77

Q28482202-277F7B05-2686-477E-BCAD-CA2F56250705

Q28482202-297BFA46-26AD-4363-9E4D-49ADE3FEC62B

Q28482202-2E4AC7FB-A697-46D9-B1B7-BD97AE248F12

Q28482202-3EC81E16-7935-4DB9-AD3F-CCA5AA1626A7

Q28482202-4F0E5BAC-A374-44D8-89B5-0BB75BBDAB66

P304

Q28482202-900C8411-3D9A-462D-8052-C1642D101CAA

P31

Q28482202-796C7335-4184-48DC-8E3A-16757F543392

P3181

Q28482202-2F717DE0-DBB6-4D38-AE88-F17635239211

P356

Q28482202-D5AF49DD-ABDA-4B29-8A4F-DE353DA5F178

P407

Q28482202-A4602695-A500-497E-AA8C-7DC17BE234C4

P433

Q28482202-8BBEE6AD-C2BE-448C-A4A0-6711B55AFA85

P478

Q28482202-2A77B94F-02E9-4172-A23B-BB8DB5800013

P577

Q28482202-8EBDFBDD-CE20-45C8-BEC6-67FBDB69DEBE

P5875

Q28482202-3D2CA9C5-8A1B-4885-9196-C2C63653985D

P698

Q28482202-369A7121-97A7-476F-946B-0E206601926E

P932

Q28482202-9A31CC8E-ED9B-4551-99F2-111040BA5E9F

P3181

P356

JOURNAL.PONE.0035196

P1433

P1476

Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence

@en

P2093

Ennio Ongini

http://www.w3.org/2001/XMLSchema#string

John L Wallace

http://www.w3.org/2001/XMLSchema#string

Manlio Bolla

http://www.w3.org/2001/XMLSchema#string

Rory Blackler

http://www.w3.org/2001/XMLSchema#string

Stephanie Syer

http://www.w3.org/2001/XMLSchema#string

P2860

Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs

Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage

Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study

Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial

Microcirculatory disturbance in indomethacin-induced intestinal ulcer.

Nitric oxide in mucosal defense: a little goes a long way.

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.

P304

e35196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4976426

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0035196

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223978168

http://www.w3.org/2001/XMLSchema#string

P698

22496907

http://www.w3.org/2001/XMLSchema#string

P932

3322164

http://www.w3.org/2001/XMLSchema#string